Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling

BACKGROUND: Pancreatic cancer is a leading cause of cancer-related deaths in the world with a 5-year survival rate of less than 6%. Currently, there is no successful therapeutic strategy for advanced pancreatic cancer, and new effective strategies are urgently needed. Recently, an arginine deprivati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiangbo, Ma, Jiguang, Wu, Zheng, Li, Wei, Zhang, Dong, Han, Liang, Wang, Fengfei, Reindl, Katie M, Wu, Erxi, Ma, Qingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189535/
https://www.ncbi.nlm.nih.gov/pubmed/25240403
http://dx.doi.org/10.1186/1471-2407-14-686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189535/
https://www.ncbi.nlm.nih.gov/pubmed/25240403
http://dx.doi.org/10.1186/1471-2407-14-686

Ejemplares similares